Literature DB >> 15141383

Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.

Fátima Carneiro1, David G Huntsman, Thomas C Smyrk, David A Owen, Raquel Seruca, Paul Pharoah, Carlos Caldas, Manuel Sobrinho-Simões.   

Abstract

Hereditary diffuse gastric cancer (HDGC) is a familial cancer syndrome caused, in 30-40% of cases, by germline mutations of the E-cadherin/CDH1 gene. The presence of clinically undetectable early gastric cancers has been previously reported in ten of ten prophylactic gastrectomies from germline E-cadherin mutation carriers. In the present study, detailed maps of the distribution of invasive cancers in nine of these ten stomachs were produced and precursor lesions of HDGC searched for. The nine gastrectomy specimens contained from 1 to 161 foci of early diffuse gastric cancer, occupying 0.005-2.96% of the gastric mucosa. Seven specimens contained focal in situ signet ring carcinoma. Pagetoid spread of signet ring cells was observed beneath the epithelial lining of gastric foveolae/glands. Helicobacter pylori organisms and associated pathology were absent from all cases. Two-dimensional maps of the gastrectomy specimens revealed lesions throughout the gastric mucosa without evidence of antral clustering. The distribution and size of the cancers in the gastrectomy specimens indicate that standard endoscopic screening with random or geographically targeted biopsies is unlikely to provide sufficiently sensitive clinical screening for at-risk individuals. An in situ precursor of signet ring carcinoma was identified and a model for neoplastic progression in the setting of HDGC is proposed. Copyright 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15141383     DOI: 10.1002/path.1564

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  72 in total

Review 1.  A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.

Authors:  Rajini Seevaratnam; Natalie Coburn; Roberta Cardoso; Matthew Dixon; Alina Bocicariu; Lucy Helyer
Journal:  Gastric Cancer       Date:  2011-12-10       Impact factor: 7.370

2.  Treatment of resectable gastric cancer.

Authors:  Johan L Dikken; Cornelis J H van de Velde; Daniel G Coit; Manish A Shah; Marcel Verheij; Annemieke Cats
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

Review 3.  [Prophylactic gastric surgery].

Authors:  H Vogelsang; K Ott; J Mehler; G Keller; J R Siewert
Journal:  Chirurg       Date:  2005-12       Impact factor: 0.955

Review 4.  Recognition of and recent issues in hereditary diffuse gastric cancer.

Authors:  Shinya Sugimoto; Hirokazu Komatsu; Yuichi Morohoshi; Takanori Kanai
Journal:  J Gastroenterol       Date:  2015-06-07       Impact factor: 7.527

Review 5.  Hereditary diffuse gastric cancer: What the clinician should know.

Authors:  Ryan Ying Cong Tan; Joanne Ngeow
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

Review 6.  Preemptive surgery for premalignant foregut lesions.

Authors:  Rohit R Sharma; Mark J London; Laura L Magenta; Mitchell C Posner; Kevin K Roggin
Journal:  J Gastrointest Surg       Date:  2009-06-10       Impact factor: 3.452

Review 7.  Hereditary diffuse gastric cancer: prophylactic surgical oncology implications.

Authors:  Henry T Lynch; Edibaldo Silva; Debrah Wirtzfeld; Pamela Hebbard; Jane Lynch; David G Huntsman
Journal:  Surg Clin North Am       Date:  2008-08       Impact factor: 2.741

8.  Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC).

Authors:  Carla Oliveira; Raquel Seruca; Nicoline Hoogerbrugge; Marjolijn Ligtenberg; Fátima Carneiro
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

9.  A short guide to hereditary diffuse gastric cancer.

Authors:  Parry Guilford; Vanessa Blair; Helen More; Bostjan Humar
Journal:  Hered Cancer Clin Pract       Date:  2007-12-15       Impact factor: 2.857

Review 10.  Nature meets nurture: molecular genetics of gastric cancer.

Authors:  Anya N Milne; F Carneiro; C O'Morain; G J A Offerhaus
Journal:  Hum Genet       Date:  2009-08-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.